Skip to content
value.today

Solesence, Inc.

SLSN
$59 Mmarket cap on Oct 30, 2026
Compare
World rank
#20,733
Revenue
$62 M
For year ending December-2025
Net income
$3 M
4.5% margin
SEC filing
Employees
115
As of December 31, 2025
SEC filing

Solesence, Inc. in brief

Solesence, Inc. is a listed company in the FMCG industry, based in Romeoville, Illinois, USA. Its market value was $59 M on 30 October 2026, which makes it the 20,733rd largest listed company in the world and the 3,790th largest in the USA on this site. In the year to December 2025 it had sales of $62 M and a net profit of $3 M, about 5 cents of profit for every dollar of sales. It employs about 115 people. Its largest product and service lines by sales in 2025 were Consumer Products (88%), Personal Care ingredients (10%) and Advanced Materials (1%). Its shares trade under the symbol SLSN (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Solesence, Inc. timeline

4 events, 1997–2025
  1. 1997
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2025
  4. 💰
    Record revenue of $62 million
    FY2025, the highest of the 8 years on record.
  5. 💰
    Record net income of $3 million
    FY2025, the highest profit of the 4 years on record.
  6. ✎
    Renamed Solesence, Inc.
    Formerly Nanophase Technologies Corporation.

Events of Solesence, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$19 M$38 M$57 M$76 M

World rank over time

▼ down 642 places since 2026
2026-10-13: #20132#20,13220262026-10-30: #20774#20,7742026

Rank in USA: #3,679 (Oct 2026) · #3,794 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
21.3×
Price / sales (TTM)
1.0×
Price / book
4.2×
Free cash flow yield
-4.4%
Net margin (TTM)
4.5%
Operating margin
4.2%
Return on equity
19.6%
Liabilities / assets
69.8%
Net debt
$-1M
Revenue growth
+18.5%
R&D / revenue
6.6%
Revenue per employee
$540 K
Profit per employee
$24 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $14M, net income $-2M$14MFY18Fiscal year ending Dec 2019: revenue $13M, net income $-3M$13MFY19Fiscal year ending Dec 2020: revenue $17M, net income $1M$17MFY20Fiscal year ending Dec 2021: revenue $29M, net income $2M$29MFY21Fiscal year ending Dec 2022: revenue $37M, net income $-3M$37MFY22Fiscal year ending Dec 2023: revenue $37M, net income $-5M$37MFY23Fiscal year ending Dec 2024: revenue $52M, net income $1M$52MFY24Fiscal year ending Dec 2025: revenue $62M, net income $3M$62MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$62M+18.5%$3M$3M4.5%
Dec 2024$52M+40.3%$2M$1M2.1%
Dec 2023$37M-0.1%$-4M$-5M-13.2%
Dec 2022$37M+26.6%$-2M$-3M-7.0%
Dec 2021$29M+72.2%$3M$2M7.9%
Dec 2020$17M+36.9%$1M$1M5.8%
Dec 2019$13M-11.8%$-3M$-3M-24.1%
Dec 2018$14M—$-2M$-2M-14.7%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-9M——$0.04—
Dec 2024$2M$5M$-3M$0.02—
Dec 2023$-2M$1M$-3M$-0.10—
Dec 2022$-2M$3M$-4M$-0.05—
Dec 2021$2M$2M$0M$0.05—
Dec 2020$-2M$1M$-3M$0.03—
Dec 2019$-3M$1M$-4M$-0.08—
Dec 2018$-1M$0M$-2M$-0.06—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$61M
Net income, trailing 12 months
$3M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $13M, net income $-2M$13MDec ’24Three months to Mar 2025: revenue $15M, net income $0M$15MMar ’25Three months to Jun 2025: revenue $20M, net income $3M$20MJun ’25Three months to Sep 2025: revenue $15M, net income $-1M$15MSep ’25Three months to Dec 2025 (from the annual report): revenue $12M, net income $0M$12MDec ’25Three months to Mar 2026: revenue $13M, net income $-1M$13MMar ’26Three months to Jun 2026: revenue $15M, net income $-0M$15MJun ’26Three months to Sep 2026: revenue $20M, net income $4M$20MSep ’26

Latest quarter to Sep 2026: revenue $20M (+38.1% on a year earlier), net income $4M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Solesence, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$62 M
Operating income
$3 M
Net income
$3 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$46 M
Total liabilities
$32 M
Total equity
$14 M

As of December-2025

Top 34 institutional investors in Solesence, Inc.#

As of Sep 30, 2026
34 institutions held 2.7 M shares (about 3.9% of the shares outstanding) on Sep 30, 2026. The ten largest hold 3.6%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Solesence, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Vanguard Capital Management LLC813,998-16,510 (-1.99%)1.15%$1 MNov 13, 2026
2BlackRock, Inc.326,762-136,890 (-29.52%)0.46%$0 MNov 13, 2026
3Bank of New York Mellon Corp317,6090 (0.00%)0.45%$0 MNov 5, 2026
4Millennium Management LLC262,524-13,973 (-5.05%)0.37%$0 MNov 16, 2026
5Geode Capital Management, LLC229,297-9,217 (-3.86%)0.32%$0 MNov 6, 2026
6Morgan Stanley185,915-2,882 (-1.53%)0.26%$0 MNov 13, 2026
7Donaldson Capital Management, LLC150,0000 (0.00%)0.21%$0 MNov 9, 2026
8Susquehanna International Group, LLP113,202+1,862 (+1.67%)0.16%$0 MNov 16, 2026
9Vanguard Fiduciary Trust Co106,6920 (0.00%)0.15%$0 MNov 13, 2026
10Jane Street Group, LLC60,815-38,570 (-38.81%)0.09%$0 MNov 12, 2026
11Northern Trust Corp36,9320 (0.00%)0.05%$0 MNov 16, 2026
12Zacks Investment Management27,955-10,000 (-26.35%)0.04%$0 MNov 16, 2026
13Wealth Enhancement Advisory Services, LLC22,076-682 (-3.00%)0.03%$0 MOct 13, 2026
14Barclays PLC19,048-759 (-3.83%)0.03%$0 MNov 6, 2026
15Qube Research & Technologies Ltd15,239-6,799 (-30.85%)0.02%$0 MNov 13, 2026
16XTX Topco Ltd14,392New0.02%$0 MNov 16, 2026
17State Street Corp14,050-4,100 (-22.59%)0.02%$0 MNov 12, 2026
18Tower Research Capital LLC (TRC)5,417-49,858 (-90.20%)0.01%$0 MNov 16, 2026
19Royal Bank Of Canada5,190+632 (+13.87%)0.01%$0 MNov 16, 2026
20Provenance Wealth Advisors, LLC2,000New0.00%$0 MOct 30, 2026
21Wells Fargo & Company/mn1,575-13 (-0.82%)0.00%$0 MNov 16, 2026
22BNP Paribas Financial Markets1,516-127 (-7.73%)0.00%$0 MNov 12, 2026
23Vanguard Global Advisers, LLC1,2000 (0.00%)0.00%$0 MNov 13, 2026
24Osaic Holdings, Inc.1,0000 (0.00%)0.00%$0 MNov 12, 2026
25UBS Group AG754+680 (+918.92%)0.00%$0 MNov 10, 2026
Show all 34: investors 26 to 34
Institutional investors 26 to 34 in Solesence, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Jpmorgan Chase & Co5480 (0.00%)0.00%$0 MNov 12, 2026
27Russell Investments Group, Ltd.300-1,101 (-78.59%)0.00%$0 MNov 6, 2026
28FMR LLC225-17 (-7.02%)0.00%$0 MNov 10, 2026
29Citigroup Inc18-5,677 (-99.68%)0.00%$0 MNov 4, 2026
30Arax Advisory Partners14-311 (-95.69%)0.00%$0 MNov 12, 2026
31Allworth Financial LP7-43 (-86.00%)0.00%$0 MNov 17, 2026
32Rothschild Investment LLC1-15 (-93.75%)0.00%$0 MNov 10, 2026
33IFP Advisors, Inc1-10 (-90.91%)0.00%$0 MOct 16, 2026
34Essential Partners LLC1-46 (-97.87%)0.00%$0 MOct 14, 2026

Mutual funds holding Solesence, Inc.#

31 funds hold shares worth $1 M (about 1.9% of the company). Since their previous reports 7 added shares and 33 sold, selling $1 M net.
Mutual funds holding Solesence, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.597,505$0 M0.85%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.205,663$0 M0.29%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.96,187$0 M0.14%<0.01%+4.0%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC95,662$0 M0.14%<0.01%−0.8%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors68,221$0 M0.10%<0.01%+39%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC40,284$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors63,629$0 M0.09%<0.01%−81%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC31,985$0 M0.05%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC25,503$0 M0.04%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.18,234$0 M0.03%<0.01%+3.0%May 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors27,689$0 M0.04%<0.01%−80%Jun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.18,797$0 M0.03%<0.01%newJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company7,648$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.8,543$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC7,017$0 M<0.01%<0.01%−78%Jun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION4,100$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC3,959$0 M<0.01%<0.01%−80%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC3,821$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC3,513$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.1,397$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC886$0 M<0.01%<0.01%+9.0%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC692$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC694$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC960$0 M<0.01%<0.01%−80%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC832$0 M<0.01%<0.01%−87%Jun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC613$0 M<0.01%<0.01%−80%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS683$0 M<0.01%<0.01%−80%Jun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC488$0 M<0.01%<0.01%−78%Jun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC131$0 M<0.01%<0.01%−79%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.106$0 M<0.01%<0.01%+16%Jun 30, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC105$0 M<0.01%<0.01%+7.1%Jul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 31 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Solesence, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$5 K
2 purchases, 1 insider
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$5 K
open market only
Insiders on file
14
since
$28.1 M-$28.1 M$0Feb 2024: bought $1.6 M (6 trades), sold $0 (0 trades)Feb 24May 2024: bought $65 K (17 trades), sold $0 (0 trades)Jun 2024: bought $69 K (11 trades), sold $0 (0 trades)JunAug 2024: bought $46 K (9 trades), sold $0 (0 trades)Sep 2024: bought $111 K (12 trades), sold $0 (0 trades)SepOct 2024: bought $38 K (10 trades), sold $0 (0 trades)May 2025: bought $28.1 M (2 trades), sold $28.1 M (2 trades)MayJun 2025: bought $0 (0 trades), sold $166 K (2 trades)Nov 2025: bought $63 K (5 trades), sold $0 (0 trades)NovDec 2025: bought $5 K (2 trades), sold $0 (0 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Solesence, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed R. Janet WhitmoreDirectorBuy+1,500$1.910$3 K2.09 MForm 4
filed R. Janet WhitmoreDirectorBuy+1,000$1.920$2 K2.09 MForm 4
filed R. Janet WhitmoreDirectorBuy+5,000$1.950$10 K2.08 MForm 4
filed R. Janet WhitmoreDirectorBuy+5,000$1.890$9 K2.08 MForm 4
filed R. Janet WhitmoreDirectorBuy+267$1.830$4892.07 MForm 4
filed R. Janet WhitmoreDirectorBuy+5,000$1.870$9 K2.07 MForm 4
filed R. Janet WhitmoreDirectorBuy+19,789$1.730$34 K2.07 MForm 4
filed Kevin CuretonChief Operating OfficerOption exercise+38,807$0.420$16 K231,019Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Solesence, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
359,433
0.5% of shares · 19.48 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2025-04-08 14:39 UTC, code LUDP, resumed 14:44 UTC
  • 2025-04-08 14:26 UTC, code LUDP, resumed 14:36 UTC
  • 2025-04-08 13:30 UTC, code LUDP, resumed 14:25 UTC

Fails to deliver

  • : 23 shares at $0.83
  • : 1,195 shares at $0.80
  • : 2,784 shares at $1.00
  • : 5,109 shares at $0.81
  • : 219 shares at $0.85

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Solesence, Inc. scorecard#

Passes 13 of the 20 checks that could be worked out: strongest in growth (6 of 6), weakest in financial health (1 of 3). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation3 of 5
    • ✓P/E below its peers' median21.3×P/E 21.3× against FMCG's median of 23.2×.
    • ✓Price to book below its peers' median4.2×Price to book 4.2× against FMCG's median of 5.1×.
    • ✓Price to sales below its peers' median1.0×Price to sales 1.0× against FMCG's median of 2.5×.
    • ✗Free cash flow yield above 5%-4.4%Free cash flow is -4.4% of the market value.
    • ✗Earnings yield above the 10-year Treasury yield4.7%Earnings yield 4.7% against the 10-year Treasury's 5.15% on 2026-11-13.
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth6 of 6
    • ✓Revenue grew in the newest year18.6%Revenue up 18.6% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years18.5%18.5% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median18.5%18.5% a year against FMCG's median of 0.4% (30 companies).
    • ✓Earnings per share grew in the newest year0.04 vs 0.02Diluted EPS 0.04 in fiscal 2025 against 0.02 the year before (report's currency).
    • ✓Net income higher than five years earlier$3 M$3 M in fiscal 2025 against $1 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability3 of 5
    • ✓Profitable in the newest year$3 MNet income $3 M in fiscal 2025.
    • ✗Profitable in each of the last five years3 of 5Profitable in 3 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median4.2%4.2% against FMCG's median of 5.3% (40 companies).
    • ✓Return on equity above 15%23.1%23.1% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier4.2%4.2% in fiscal 2025 against -6.1% in 2022.
  • Financial health1 of 3
    • ✓Short-term assets cover short-term liabilities1.8×Current ratio 1.80 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-0.19Z-score -0.19 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year11.6%Diluted shares up 11.6% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of FMCG, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Solesence, Inc.'s statements, beside the median of FMCG.

Solesence, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin4.2%5.3%
Net margin4.5%4.1%
Return on equity23.1%11.2%
Revenue growth, 3 years a year18.5%0.4%
Revenue growth18.6%1.4%

5of 8on the Piotroski tests of financial strength

  • Only -305% of net income arrived as cash from operations.
  • The share count rose 11.6% in the year.
  • Receivables grew 40% while revenue grew 19%: customers are paying later, or sales were booked ahead of cash.

Solesence, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Solesence, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue62523737291713141211
Cost of revenue45r39r30r2921119.9118.67.5
Gross profit17r13r7.3r8.48.76.02.63.33.93.2
Research and development4.13.83.83.02.21.61.92.11.71.6
Selling, general and administrative107.27.57.63.92.93.53.32.93.0
Total costs and expenses59r51r42r———————
Operating income2.6r2.0r−4.1r−2.32.61.5−2.8−2.0−0.8−1.3
Interest and finance income0.2—————————
Interest expense and finance costs—0.70.80.41.20.50.20.10.00.0
Other non-operating income (expense)————————0.0—
Income before tax2.9r1.3r−4.9r−2.62.41.0−3.0−2.1−0.8−1.3
Income tax0.10.20.0−0.00.0——00—
Net income attributable to shareholders2.8r1.1r−4.9r−2.62.31.0−3.0−2.1−0.8−1.3
Earnings per share, basic0.04r0.02r-0.10r-0.050.050.03-0.08-0.06-0.03-0.04
Earnings per share, diluted0.04r0.02r-0.10r-0.050.050.03-0.08-0.06-0.03-0.04
Shares, weighted average (basic)70625049453837———
Shares, weighted average (diluted)73655049473937343131
Balance sheet
Cash and cash equivalents1.31.41.72.20.71.01.21.32.01.8
Receivables6.84.93.54.73.92.91.00.81.10.4
Inventory15r16r8.5r8.86.14.32.62.21.4r0.8
Other current assets2.12.81.10.90.90.60.30.30.2r0.4
Current assets25r25r15r17128.85.04.74.63.4
Property, plant and equipment14138.77.94.72.92.31.91.61.4
Right-of-use (leased) assets6.97.97.99.0121.82.1———
Total assets46r45r31r3428149.46.66.34.8
Accounts payable4.19.16.36.43.62.11.71.61.00.7
Debt due within a year—————0.50.5———
Current liabilities142616r14r7.3r6.84.43.62.01.3
Long-term debt———1.01.01.0————
Lease liabilities (non-current)7.89.09.29.812r1.72.0———
Non-current liabilities189.315r14r14r4.03.51.51.00.8
Retained earnings−102r−105r−106r−100−97−100−101−98−96−95
Shareholders' equity14r10r0.4r4.7r7.52.71.51.43.22.8
Total liabilities and equity46r45r31r3428149.46.66.34.8
Shares outstanding71705049493838r343431
Cash-flow statement
Depreciation and amortization0.90.90.70.60.50.40.30.30.30.6
Share-based compensation0.60.70.80.60.20.20.20.20.20.2
Cash from operating activities−8.62.0−2.0−1.72.3−2.1−2.8−1.3−1.0−0.2
Capital expenditure—−4.6−1.1−2.8−1.9−0.9−0.7−0.2−0.2−0.1
Cash from investing activities−2.1−4.6−1.1−2.8−1.9−0.9−0.7−0.2−0.1−0.2
Shares issued0.32.1————1.7—1.01.0
Cash from financing activities112.32.66.0−0.72.73.40.91.20.9
Change in cash−0.1−0.3−0.51.5−0.3−0.2−0.2−0.60.20.5
Report10-K/A10-K/A10-K/A10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Solesence, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Product(total)$62 M100%
  • Consumer Products$55 M88%
  • Personal Care ingredients$6 M10%
  • Advanced Materials$1 M1.4%
  • Product and Service, Other$0 M0.4%

Countries and regions

  • Non-US(total)$5 M8.3%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Events at Solesence, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling
  • Financial statements withdrawnFiling

Delisting notice 1 · Financial statements withdrawn 1 · Directors and officers 4 · Material agreement 6 · Bylaws or fiscal year changed 3 · Shareholder vote 3 · Results announced 8

Solesence, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Material agreement8-K
Delisting notice8-K
Financial statements withdrawn8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Directors and officersMaterial agreement8-K
Results announced8-K
Material agreement8-K
Directors and officersMaterial agreement8-K
Shareholder vote8-K
Results announced8-K
Bylaws or fiscal year changed8-K
Material agreement8-K
Results announced8-K
Results announced8-K
Bylaws or fiscal year changed8-K
Bylaws or fiscal year changedShareholder vote8-K
Shareholder vote8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

Private share sales · funding history

Private share sales of Solesence, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2017$1 MPrivate placement after listingUnder $2 million1equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Solesence, Inc.#

1 labor condition applications certified in fiscal 2025 for 1 positions, at a median wage of $79 K a year.

Certified, FY2025
1
#2,047 among companies on value.today
Worker positions
1
Median wage offered
$79 K
a year, full-time
Applications filed
1
Solesence, Inc.: most frequent H-1B job titles in fiscal 2025
Job titlePositionsMedian wage offered
QC Chemist IIChemists1$79 K

Where: Romeoville, IL 1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Solesence Inc.

How Solesence, Inc. compares in FMCG

  • Market cap$59 M · higher than 18% of 110
  • Revenue$62 M · higher than 10% of 104
  • Net margin4.5% · higher than 38% of 103
  • Revenue growth18.6% · higher than 93% of 46
  • P/E ratio21.3× · lower than 52% of 61
  • Price / sales1.0× · lower than 76% of 72
  • Price / book4.2× · lower than 34% of 71
  • FCF yield-4.4% · higher than 12% of 34

Peer comparison · FMCG

CompanyMarket capP/ENet marginRev. growth
Solesence, Inc.🇺🇸$59 M21.3×4.5%+18.6%
The Procter & Gamble Company🇺🇸$372.2 B23.2×18.2%+3.3%
L'Oréal S.A.🇫🇷$241.7 B33.3×13.9%+5.5%
Unilever PLC🇬🇧$135.7 B12.7×18.8%+0.3%
Colgate-Palmolive Company🇺🇸$74.8 B36.4×9.7%+1.4%
Hindustan Unilever Limited🇮🇳$52.2 B32.2×23.6%—
Reckitt Benckiser Group PLC🇬🇧$44.3 B10.2×22.4%+3.3%
Haleon plc🇬🇧$42.6 B19.4×15.1%+1.2%
The Estée Lauder Companies Inc.🇺🇸$39.6 B107.6×2.4%+5.0%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Solesence, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Solesence, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Solesence, Inc.? Suggest a correction